NCT06859710View on ClinicalTrials.gov

THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2028

Conditions
Abuse, DrugPain
Interventions
DRUG

Placebo

Vaporized Placebo

DRUG

THC

Vaporized THC (20 mg)

DRUG

CBD 20 mg

Vaporized CBD (20 mg)

DRUG

CBD 40 mg

Vaporized CBD (40 mg)

DRUG

CBD 80 mg

Vaporized CBD (80 mg)

Trial Locations (1)

90095

RECRUITING

UCLA Center for Cannabis and Cannabinoids, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER